Brainstorm Cell Therapeutics Inc.
BCLI
$0.642
-$0.0032-0.50%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -76.25% | 111.04% | -85.62% | -88.15% | 363.77% |
Total Receivables | 221.21% | 157.69% | 23.53% | -39.39% | -64.52% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 86.31% | 36.78% | -75.36% | 183.64% | -15.59% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -60.30% | 85.23% | -79.73% | -76.35% | 214.59% |
|
|||||
Total Current Assets | -60.30% | 85.23% | -79.73% | -76.35% | 214.59% |
Net Property, Plant & Equipment | -50.48% | -45.15% | -40.88% | -64.63% | -63.03% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -100.00% | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 13.07% | 0.99% | -0.48% | 866.67% | 804.55% |
Total Assets | -54.85% | 6.66% | -56.46% | -64.36% | -1.11% |
|
|||||
Total Accounts Payable | 12.30% | 44.93% | 22.73% | 17.24% | 2.89% |
Total Accrued Expenses | -48.89% | -15.41% | -50.08% | 1,273.02% | 697.78% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -32.69% | -24.66% | -8.96% | -56.36% | -58.20% |
Total Finance Division Other Current Liabilities | 57.64% | 109.71% | 42.57% | 1.75% | 0.95% |
Total Other Current Liabilities | 57.64% | 109.71% | 42.57% | 1.75% | 0.95% |
Total Current Liabilities | 10.88% | 59.58% | 15.10% | 12.04% | 0.00% |
|
|||||
Total Current Liabilities | 10.88% | 59.58% | 15.10% | 12.04% | 0.00% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -76.01% | -76.17% | -74.55% | -82.90% | -79.57% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -24.75% | 103.63% | -- |
Total Liabilities | -6.37% | 23.94% | 5.85% | -2.20% | -4.35% |
|
|||||
Common Stock & APIC | 4.10% | 4.31% | 4.15% | 5.20% | 6.41% |
Retained Earnings | -5.18% | -5.08% | -5.41% | -6.79% | -6.12% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -71.73% | -34.36% | -59.82% | -134.59% | 9.14% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -71.73% | -34.36% | -59.82% | -134.59% | 9.14% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -71.73% | -34.36% | -59.82% | -134.59% | 9.14% |
|